In our study, 61.70% of patients with HAS had significantly elevated serum AFP levels, which may be a result of the dedifferentiation of cancer cells into hepatoid adenocarcinoma progenitor cells. The gene discussed is AFP; the disease is hepatoid adenocarcinoma.